BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, January 11, 2025
See today's BioWorld
Home
» Other news to note for March 16, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for March 16, 2021
March 16, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AC Immune, Alchemab, Allero, Ampio, Astrazeneca, Atai, Boehringer, Can-Fite, Cohbar, Cure, Diverse, Elevation Oncology, Enveric, Evaxion, Ewopharma, GBT, Horizon, Immunoprecise, Immutep, Intelgenx, Italfarmaco, Luye, Merck & Co., Neogenomics, Nurix, Otsuka, Pandion, Perception, Purdue, Sanofi, Skye, Viela.
BioWorld
Briefs
Other news to note
Coronavirus